Esplanade Ventures — 2021 Investments
4 investments dated 2021 · listed companies and verified rows first · show all
Osteoboost is an FDA-cleared bone health solution designed for postmenopausal women with osteopenia.
BiotechFemTechHealthtechLongevityMedical DevicesRedwood City, US
Dr. Dan Burnett(Founder & CEO of Theranova and Osteoboost Co-Founder)Dr. Shane Mangrum(PM&R Physician and Osteoboost Co-Founder)Laura Yecies(Chief Executive Officer & President)in
BoardMichael Jaasma(Chief Scientific Officer and Osteoboost Co-Founder)inJohn Osborne(Director)
Co-investorsAmbit Health VenturesBand of AngelsBerkeley Angel NetworkGolden SeedsHouston Angel NetworkIT-Farm Corporation+2 more
Cleerly develops FDA-cleared, AI-driven analysis of noninvasive coronary CT (CCTA) imaging to characterize and quantify coronary artery disease.
AI & Machine LearningDigital HealthHealthtechMedical DevicesDenver, US
James Min, MD(Founder)inJames K. Min(Founder)
BoardLee Cooper(Director)Peter Justin Klein(Director)Scott Barclay(Director)inLouis Samson(Director)
Co-investorsBattery VenturesBreyer CapitalCatalytic Impact FoundationDigiTx Partners LLCInsight PartnersLRVHealth+6 more
KixCare provides 24/7 virtual pediatric physical and mental healthcare for children in Canada, serving families, employers, insurers, advisors, and healthcare professionals.
Digital HealthHealthtechMental Health
Sana Health develops an audiovisual device intended to help users improve physical recovery and mental well-being, targeting relief and more restful states of mind.
Digital HealthHealthtechMedical DevicesMental HealthLafayette, US
Richard Hanbury(Founder)in
Co-investorsAlumni VenturesAsia Africa Investment & Consulting (AAIC)Checkmate Capital Group LLCClick VenturesFlucas VenturesGaingels+12 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



















__Twitter.png)